Ventyx Biosciences, Inc.
VTYX
$2.72
$0.072.64%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -119.03M | -123.99M | -135.12M | -152.52M | -171.30M |
| Total Depreciation and Amortization | 1.30M | 1.30M | 1.35M | 1.44M | 1.39M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.63M | 12.39M | 13.46M | 14.33M | 17.36M |
| Change in Net Operating Assets | -611.00K | 1.34M | -10.56M | -22.52M | -5.93M |
| Cash from Operations | -105.71M | -108.97M | -130.87M | -159.28M | -158.48M |
| Capital Expenditure | -64.00K | -82.00K | -241.00K | -446.00K | -494.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 69.92M | -30.77M | -15.27M | 42.06M | 51.76M |
| Cash from Investing | 69.86M | -30.86M | -15.51M | 41.62M | 51.26M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 302.00K | 234.00K | 96.42M | 96.63M | 98.32M |
| Repurchase of Common Stock | -- | -906.00K | -906.00K | -906.00K | -906.00K |
| Issuance of Preferred Stock | 26.85M | 26.85M | 26.85M | 26.85M | -- |
| Repurchase of Preferred Stock | -247.00K | -247.00K | -247.00K | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 151.00K | 73.00K |
| Cash from Financing | 26.91M | 25.93M | 122.12M | 122.73M | 97.49M |
| Foreign Exchange rate Adjustments | 320.00K | 69.00K | -55.00K | 92.00K | -84.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.62M | -113.82M | -24.32M | 5.16M | -9.82M |